HCV E1E2 vaccine compositions
Details for Australian Patent Application No. 2002322358 (hide)
International Classifications
Event Publications
16 January 2003 Complete Application Filed
Priority application(s): 60/302,227 29.06.01 US
15 May 2003 Application Open to Public Inspection
Published as AU-B-2002322358
20 January 2005 Amendment Made
The nature of the amendment is: Add co-inventor to Fong, Yiu-Lian 2003
30 October 2008 Alteration of Name
The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc. Amendments
18 June 2009 Application Accepted
Published as AU-B-2002322358
15 October 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002322357-METHOD AND APPARATUS FOR COMPUTER MODELING OF AN ADAPTIVE IMMUNE RESPONSE
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser